Thursday, August 1, 2013

The Theory Behind Insulin Potentiation Therapy (IPT)


The challenge modern medical professionals face with chemotherapy is that the toxic chemicals attack both healthy cells and cancer cells, wreak havoc on the patient's immune system, and generally degrade the patient's quality of life. Often, patients find that the treatment is far worse than the disease. However, the cancer treatment alternative Insulin Potentiation Therapy (IPT) offers a gentler alternative with targeted attacks on cancerous cells and enhanced patient comfort through low-dose chemotherapy.

As an alternative cancer treatment, Insulin Potentiation Therapy (IPT) with low-dose chemotherapy is based on the theory that insulin increases the effectiveness of disease fighting drugs like chemotherapy. Here's the basic theory:

Insulin reacts with insulin receptors.

On every cell, there are receptors that react with insulin to regulate cell glucose (sugar) intake, to oversee gene reproduction and to promote cell growth. Insulin is one of the basic metabolic hormones in the body.

Insulin increases the uptake of medicines into cells.

Through significant research and study, insulin has been shown to increase concentrations of medications in cells, possibly by making the membrane more permeable or by carrying the medication into the cell in a process called endocytosis.

Cancer cells have more insulin receptors.

Insulin is a growth factor that increases the growth rate, division rate and proliferation of cells. Cancer cells proliferate uncontrollably, sometimes secreting growth hormones themselves to speed up the process. Cancer cells are believed to have more growth-hormone receptors than normal cells. Growing and dividing requires fuel - i.e. glucose. Because cancer cells grow more rapidly than normal cells, it follows that they have a greater ability to intake sugar. The intake of sugar is facilitated by insulin. Thus, cancer cells must have more insulin receptors.

Insulin stimulates cell division, making cancer cells more susceptible to toxic drugs.

It is known that insulin will stimulate other growth receptors on cells, increasing cell metabolism and stimulating cell division. During IPT, a patient is given a dose of insulin and it is believed that cancer cells will be trigged to go into the phase of cell division where they are more susceptible to toxic drugs. Because the cancer cells have more growth-hormone receptors, they will be triggered more than normal cells, therefore more cancer cells will be killed than normal cells.

Less chemotherapeutic drugs are needed.

IPT uses lower doses of chemotherapeutic drugs than standard chemotherapy because the added insulin targets cancer cells over healthy cells, making the process more efficient. As a result, patients do not experience as severely the negative side-effects of chemotherapy. Scientific research and individual case studies have shown a greater quality of life in patients who have undergone IPT.

Since the 1930s when IPT was first developed, there have been many studies to test the effectiveness of IPT. While the specifics of IPT are not completely proven, the evidence suggests benefits over traditional cancer treatments. As the research begins to grow, IPT may become a more mainstream cancer treatment.

At EuroMed, we have the largest number of IPT trained physicians in the world. We are devoted to holistic cancer treatment and recommend IPT to many of our patients because it allows them to focus on their health, without the debilitating effects of traditional chemotherapy.

No comments:

Post a Comment